Vanta Bioscience (540729.BO) Osake Kurssi

Vanta Bioscience Ltd is a company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Secunderabad, India, the company provides preclinical contract research services. It went public through an IPO on October 6, 2017. Vanta Bioscience offers a range of services including testing and contract research in clinical research, pre-clinical research, biopharma services, analytical testing, and environmental studies. The company serves clients from various industries such as pharmaceuticals, medical devices, nutraceuticals, feed additives, biotechnology, agrochemicals, cosmetics, and chemicals. Their services include preclinical safety assessment, risk assessment for active pharmaceutical ingredients (APIs), excipients, extractables and leachables, and pharmaceutical impurities. Additionally, Vanta Bioscience provides services for determining health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), as well as occupational exposure limits (OEL) for pharmaceutical manufacturers. The company's website is www.vantabio.com. Vanta Bioscience Ltd is listed on the Bombay Stock Exchange under the ticker 540729.BO and has the ISIN INE695X01011. The company focuses on delivering comprehensive preclinical research solutions to support the development and safety evaluation of products across multiple sectors.